Skip to main content
Fig. 4 | Respiratory Research

Fig. 4

From: Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies

Fig. 4

Pooled analysis of mean a daily, b daytime, and c nighttime number of rescue medication puffs, and d percentage of days with no rescue medication use over 12 weeks by smoking status (FAS). *P < 0.05, ***P < 0.001 vs placebo. FAS, full analysis set; GLY, glycopyrrolate; LSM, least squares mean; SE, standard error

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us